OCGN: Ocugen, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 369.36
Enterprise Value ($M) 333.98
Book Value ($M) 40.56
Book Value / Share 0.16
Price / Book 9.11
NCAV ($M) 18.99
NCAV / Share 0.07
Price / NCAV 19.45

Profitability (mra)
Return on Invested Capital (ROIC) -1.29
Return on Assets (ROA) -0.66
Return on Equity (ROE) -0.83

Liquidity (mrq)
Quick Ratio 2.51
Current Ratio 2.51

Balance Sheet (mrq) ($M)
Current Assets 42.97
Assets 64.55
Liabilities 23.98
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 6.04
Operating Income -65.53
Net Income -63.08
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -62.05
Cash from Investing 3.08
Cash from Financing 20.88

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-13 13G/A Vanguard Group Inc 4.69 1.52
01-22 13G/A State Street Corp 0.33 -86.23
07-07 13G/A BlackRock Inc. 1.50 -74.06

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-04-16 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-08-21 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-05-05 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-19 1,955,673 5,919,382 33.04
2024-04-18 2,604,340 1,125,479 231.40
2024-04-17 2,426,869 7,220,787 33.61
2024-04-16 1,046,010 2,985,052 35.04
2024-04-15 2,222,952 6,894,779 32.24

(click for more detail)

Similar Companies
NTBL – Notable Labs, Ltd. NVCT – Nuvectis Pharma, Inc.
OCEA – Ocean Biomedical, Inc. OCUP – Ocuphire Pharma, Inc.
OCX – OncoCyte Corporation


Financial data and stock pages provided by
Fintel.io